Brian A Jackson / Shutterstock.com
A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
GSK, patent, intellectual property, research & development, pharmaceutical, BIO Latin America; Trust in Science,